HTFL
Neutral signalScored 2026-10-18 Drivers: trend, fundamentals. Insiders: neutral. Moteurs : tendance, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
Heartflow, Inc. Common Stock
- Nom
- Heartflow, Inc. Common Stock
- Secteur
- Healthcare
- Industrie
- Medical - Healthcare Information Services
- Bourse
- NASDAQ
- Capitalisation
- $4.9B
- Employés
- 843
- PDG
- John Farquhar
- Site web
- https://www.heartflow.com
- Marché
- CDIOHSCS
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 77 800 titres (~3 747 799,88 $ US)
- Insiders
- Farquhar John C.M.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$14,173,736
Avg sell (VWAP, 90d window) $46.61 vs last close $55.82 (+19.8%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$14,173,736 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-10-12
- Liquidity
- Liquid $91,824,402/day · 20d vol
- Last synced
-
2026-10-21 21:10:33
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-12 | Farquhar John C.M. | Sell · S · 10b5-1 | 38,900 | $49.57 | $1,928,195 | Form 4 |
| 2026-09-18 | Rogers Campbell | Sell · S · 10b5-1 | 19,682 | $50.15 | $987,052 | Form 4 |
| 2026-09-18 | Verghese Vikram | Sell · S · 10b5-1 | 16,766 | $50.75 | $850,926 | Form 4 |
| 2026-09-17 | Verghese Vikram | Sell · S · 10b5-1 | 7,579 | $50.11 | $379,816 | Form 4 |
| 2026-09-15 | Verghese Vikram | Sell · S · 10b5-1 | 668 | $50.01 | $33,408 | Form 4 |
| 2026-09-14 | Verghese Vikram | Sell · S · 10b5-1 | 4,593 | $50.24 | $230,744 | Form 4 |
| 2026-09-11 | Verghese Vikram | Sell · S · 10b5-1 | 29,714 | $50.06 | $1,487,459 | Form 4 |
| 2026-09-11 | Farquhar John C.M. | Sell · S · 10b5-1 | 3,890 | $50.00 | $194,500 | Form 4 |
| 2026-09-10 | Farquhar John C.M. | Sell · S · 10b5-1 | 35,010 | $46.42 | $1,625,105 | Form 4 |
| 2026-09-08 | Verghese Vikram | Sell · S · 10b5-1 | 6,640 | $50.03 | $332,212 | Form 4 |
| 2026-09-03 | Verghese Vikram | Sell · S · 10b5-1 | 27,540 | $49.69 | $1,368,471 | Form 4 |
| 2026-09-02 | Verghese Vikram | Sell · S · 10b5-1 | 5,876 | $50.60 | $297,326 | Form 4 |
| 2026-08-21 | Farquhar John C.M. | Sell · S · 10b5-1 | 27,230 | $50.00 | $1,361,500 | Form 4 |
| 2026-08-18 | Farquhar John C.M. | Sell · S · 10b5-1 | 32,676 | $45.00 | $1,470,420 | Form 4 |
| 2026-08-17 | Rogers Campbell | Sell · S · 10b5-1 | 9,219 | $41.23 | $380,099 | Form 4 |
| 2026-08-14 | Farquhar John C.M. | Sell · S · 10b5-1 | 15,560 | $39.06 | $607,774 | Form 4 |
| 2026-08-10 | Farquhar John C.M. | Sell · S · 10b5-1 | 22,562 | $28.31 | $638,730 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-10-18 Drivers: trend, fundamentals. Insiders: neutral. Moteurs : tendance, fondamentaux. Initiés : neutre.
HTFL combines a weak catalyst score (10) driven by heavy insider selling from both CEO and CFO with no positive event catalyst, against a fundamentally fragile operational profile marked by persistent operating losses…
The first sentence of the analysis written for HTFL on 2026-10-18 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. – Insider: neutral. All sales (≈ $14.2M) were pre-planned Rule 10b5-1 trades, excluded from the score. No open-market buys or discretionary sales. – Initiés : neutre. Toutes les ventes (≈ $14.2M) sont sous plan 10b5-1 préétabli, exclues du score. Aucun achat ni vente discrétionnaire.
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Supports a bullish reading. Interesting trend — weekly bias up
- Financial indicators Unavailable or mixed. Current ratio 5.20 · operating margin -36% — readings disagree
Suggested stop 50.25, nearest stored support minus 0.5 ATR(10.0% under the last close). Research, not advice. Not an order.
Recent news
- 2026-10-07 Heartflow (NASDAQ:HTFL) Sets New 12-Month High – Should You Buy? Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)''s stock price hit a new 52-week high on Monday. The company traded as high as $52.49 and last traded at $51.8950, with a volume of 819255 shares traded. The stock had previously closed at $49.32. Analysts Set New Price Targets HTFL has been the topic of several recent
- 2026-09-20 Vikram Verghese Sells 7,579 Shares of Heartflow (NASDAQ:HTFL) Stock Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm''s stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $50.11, for a total value of $379,783.69. Following the completion of the transaction, the chief financial officer owned 171,949 shares in the
- 2026-09-20 Heartflow (NASDAQ:HTFL) Reaches New 52-Week High – Still a Buy? Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)''s share price reached a new 52-week high during trading on Friday. The company traded as high as $52.22 and last traded at $51.2010, with a volume of 1599729 shares. The stock had previously closed at $49.57. Wall Street Analysts Forecast Growth A number of research analysts recently
- 2026-09-18 12,278 Shares in Heartflow, Inc. $HTFL Bought by Amundi Amundi bought a new stake in Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 12,278 shares of the company''s stock, valued at approximately $360,000. A number of other institutional investors also recently
- 2026-09-16 John C.M. Farquhar Sells 35,010 Shares of Heartflow (NASDAQ:HTFL) Stock Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20. Following the completion of the transaction, the chief executive officer owned 325,804 shares of the company''s
- 2026-09-15 HeartFlow''s CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the filing.
- 2026-09-11 Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysis American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Valuation and Earnings This table compares American Well and
- 2026-09-06 HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85. The traded shares represent 13% of the equity stake held by the officer before the transaction.
- 2026-09-04 Baron SMID Cap ETF Q2 2026 Portfolio Activity During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus electrons" software provider with huge competitive moats. We sold the HeartFlow position in the quarter as we grew incrementally more concerned with the presence of competitors on the market.
- 2026-09-01 Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFL Bank of New York Mellon Corp bought a new stake in shares of Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund bought 650,849 shares of the company''s stock, valued at approximately $19,096,000. Bank of New York Mellon Corp owned
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Gross Profit Margin | 76.8% | 75.1% | 66.6% | |
| Ebit Margin | -57.8% | -58.5% | -80.8% | |
| Ebitda Margin | -52.9% | -52.0% | -72.1% | |
| Operating Profit Margin | -36.4% | -48.7% | -83.6% | |
| Pretax Profit Margin | -66.4% | -76.6% | -109.1% | |
| Continuous Operations Profit Margin | -66.3% | -76.6% | -109.7% | |
| Net Profit Margin | -66.3% | -76.6% | -109.7% | |
| Bottom Line Profit Margin | -66.3% | -76.6% | -141.9% | |
| Current Ratio | 5.197 | 2.449 | 4.524 | |
| Quick Ratio | 5.197 | 2.449 | 4.524 | |
| Solvency Ratio | -1.840 | -0.090 | -0.091 | |
| Cash Ratio | 1.057 | 1.529 | 3.741 | |
| Price To Earnings Ratio | -21.277 | -18.791 | -14.820 | |
| Price To Earnings Growth Ratio | 2.035 | 0.889 | 0.000 | |
| Forward Price To Earnings Growth Ratio | 2.035 | 0.889 | 0.000 | |
| Price To Earnings Diluted Ratio | -21.277 | -18.791 | -14.820 | |
| Price To Earnings Diluted Growth Ratio | 2.035 | 0.889 | 0.000 | |
| Price To Book Ratio | 8.269 | -2.109 | -2.361 | |
| Price To Sales Ratio | 14.122 | 14.411 | 21.062 | |
| Price To Free Cash Flow Ratio | -42.100 | -24.714 | -22.244 | |
| Price To Operating Cash Flow Ratio | -46.016 | -26.275 | -24.021 | |
| Debt To Assets Ratio | 0.061 | 1.351 | 0.868 | |
| Debt To Equity Ratio | 0.073 | -0.187 | -0.207 | |
| Debt To Capital Ratio | 0.068 | -0.229 | -0.260 | |
| Long Term Debt To Capital Ratio | 0.000 | -0.189 | -0.208 | |
| Financial Leverage Ratio | 1.196 | -0.138 | -0.238 | |
| Working Capital Turnover Ratio | 1.554 | 1.531 | 0.000 | |
| Operating Cash Flow Ratio | -1.275 | -2.053 | -2.329 | |
| Operating Cash Flow Sales Ratio | -0.307 | -0.548 | -0.877 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.093 | 1.063 | 1.080 | |
| Debt Service Coverage Ratio | -6.132 | -2.878 | -2.566 | |
| Interest Coverage Ratio | -4.222 | -2.689 | -2.953 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -2.450 | -0.430 | -0.476 | |
| Capital Expenditure Coverage Ratio | -10.751 | -15.837 | -12.520 | |
| Dividend Paid And Capex Coverage Ratio | -10.751 | -15.837 | -12.520 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -26.452 | -29.357 | -29.827 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 76.8% | ▲1.7% | ▲4.0% |
| Ebit Margin | -57.8% | ▲0.7% | ▲7.9% |
| Ebitda Margin | -52.9% | ▼-0.9% | ▲6.1% |
| Operating Profit Margin | -36.4% | ▲12.3% | ▲19.8% |
| Pretax Profit Margin | -66.4% | ▲10.2% | ▲17.6% |
| Continuous Operations Profit Margin | -66.3% | ▲10.3% | ▲17.9% |
| Net Profit Margin | -66.3% | ▲10.3% | ▲17.9% |
| Bottom Line Profit Margin | -66.3% | ▲10.3% | ▲28.6% |
| Current Ratio | 5.197 | ▲2.748 | ▲1.141 |
| Quick Ratio | 5.197 | ▲2.748 | ▲1.141 |
| Solvency Ratio | -1.840 | ▼-1.750 | ▼-1.166 |
| Cash Ratio | 1.057 | ▼-0.472 | ▼-1.052 |
| Price To Earnings Ratio | -21.277 | ▼-2.486 | ▼-2.981 |
| Price To Earnings Growth Ratio | 2.035 | ▲1.145 | ▲1.060 |
| Forward Price To Earnings Growth Ratio | 2.035 | ▲1.145 | ▲1.060 |
| Price To Earnings Diluted Ratio | -21.277 | ▼-2.486 | ▼-2.981 |
| Price To Earnings Diluted Growth Ratio | 2.035 | ▲1.145 | ▲1.060 |
| Price To Book Ratio | 8.269 | ▲10.378 | ▲7.003 |
| Price To Sales Ratio | 14.122 | ▼-0.289 | ▼-2.409 |
| Price To Free Cash Flow Ratio | -42.100 | ▼-17.386 | ▼-12.414 |
| Price To Operating Cash Flow Ratio | -46.016 | ▼-19.741 | ▼-13.912 |
| Debt To Assets Ratio | 0.061 | ▼-1.290 | ▼-0.699 |
| Debt To Equity Ratio | 0.073 | ▲0.260 | ▲0.180 |
| Debt To Capital Ratio | 0.068 | ▲0.298 | ▲0.209 |
| Long Term Debt To Capital Ratio | 0.000 | ▲0.189 | ▲0.132 |
| Financial Leverage Ratio | 1.196 | ▲1.334 | ▲0.922 |
| Working Capital Turnover Ratio | 1.554 | ▲0.023 | ▲0.526 |
| Operating Cash Flow Ratio | -1.275 | ▲0.778 | ▲0.611 |
| Operating Cash Flow Sales Ratio | -0.307 | ▲0.242 | ▲0.271 |
| Free Cash Flow Operating Cash Flow Ratio | 1.093 | ▲0.030 | ▲0.014 |
| Debt Service Coverage Ratio | -6.132 | ▼-3.254 | ▼-2.273 |
| Interest Coverage Ratio | -4.222 | ▼-1.533 | ▼-0.934 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | -2.450 | ▼-2.019 | ▼-1.331 |
| Capital Expenditure Coverage Ratio | -10.751 | ▲5.086 | ▲2.285 |
| Dividend Paid And Capex Coverage Ratio | -10.751 | ▲5.086 | ▲2.285 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -26.452 | ▲2.905 | ▲2.093 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Market cap | $2.49B | $1.81B | $1.84B | |
| Enterprise value | $2.46B | $1.92B | $1.87B | |
| EV / Sales | 13.99x | 15.28x | 21.50x | |
| EV / Op. cash flow | -45.60x | -27.86x | -24.52x | |
| EV / Free cash flow | -41.72x | -26.20x | -22.70x | |
| EV / EBITDA | -26.45x | -29.36x | -29.83x | |
| Net debt / EBITDA | 0.24x | -1.67x | -0.60x | |
| Current ratio | 5.20x | 2.45x | 4.52x | |
| Income quality | 0.46x | 0.72x | 0.80x | |
| Graham net-net | $2 | -$14 | -$13 | |
| Tax burden | 99.9% | 100.1% | 100.6% | |
| Interest burden | 114.9% | 130.9% | 135.1% | |
| Working capital | $177.8M | $48.7M | $115.6M | |
| Invested capital | $203.9M | $76.4M | $146.5M | |
| Return on assets | -32.5% | -81.2% | -51.7% | |
| Operating ROA | -26.8% | -40.3% | 0.0% | |
| Return on tangible assets | -32.5% | -86.9% | -54.0% | |
| Return on equity | -38.8% | 11.2% | 12.3% | |
| Return on invested capital | -19.8% | -67.6% | -46.3% | |
| Return on capital employed | -20.2% | -71.9% | -47.9% | |
| Earnings yield | -4.7% | -5.3% | -5.2% | |
| Free cash flow yield | -2.4% | -4.0% | -4.5% | |
| Capex / Op. cash flow | -9.3% | -6.3% | -8.0% | |
| Capex / Depreciation | 58.6% | 53.6% | 80.4% | |
| Capex / Sales | 2.9% | 3.5% | 7.0% | |
| SG&A / Sales | 76.3% | 89.1% | 109.1% | |
| R&D / Sales | 36.9% | 34.6% | 41.1% | |
| Stock comp / Sales | 7.9% | 8.1% | 13.6% | |
| Intangibles / Total assets | 0.0% | 6.5% | 4.3% | |
| Days sales outstanding | 61d | 79d | 94d | |
| Days payables outstanding | 28d | 33d | 36d | |
| Operating cycle | 61d | 79d | 94d | |
| Cash conversion cycle | 33d | 45d | 58d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years